Literature DB >> 1569182

Restricted use of fetal VH3 immunoglobulin genes by unselected B cells in the adult. Predominance of 56p1-like VH genes in common variable immunodeficiency.

J Braun1, L Berberian, L King, I Sanz, H L Govan.   

Abstract

The large VH3 family of human immunoglobulin genes is commonly used throughout B cell ontogeny. However, B cells of the fetus and certain autoantibody-producing clones are restricted to a recurrent subset of VH3 genes, and VH3 B cells are deficient in certain immunodeficiency diseases. In this study, we have sequenced a set of rearranged VH3 genes generated by genomic polymerase chain reaction (PCR) from normal adults and those with common variable immunodeficiency (CVI). In both groups, all cones were readily identifiable with the fetal VH3 subset, and were further distinguished by limited DH motifs and exclusive use of JH4. In CVI, the residual population of VH3 B cells were notable for predominant use of 56p1-like VH genes. All clones displayed sequence divergence (including somatic mutation) with evidence of strong selection against complementarity-determining region (CDR) coding change. A survey of other V gene families indicates that human V gene diversity may be restricted in general by germline mechanisms. These findings suggest that the expressed antibody repertoire in the human adult may be much smaller than anticipated, and selected by processes in part distinct from the paradigm of maximal antigen-binding diversity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569182      PMCID: PMC443008          DOI: 10.1172/JCI115728

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Comparison of D, JH, and junctional diversity in the fetal, adult, and aged B cell repertoires.

Authors:  L A Bangs; I E Sanz; J M Teale
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

2.  Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.

Authors:  T J Kipps; S F Duffy
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  In rat B lymphocyte genesis sixty percent is lost from the bone marrow at the transition of nondividing pre-B cell to sIgM+ B lymphocyte, the stage of Ig light chain gene expression.

Authors:  G J Deenen; I Van Balen; D Opstelten
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

4.  Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases.

Authors:  T Olee; P M Yang; K A Siminovitch; N J Olsen; J Hillson; J Wu; F Kozin; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  Early restriction of the human antibody repertoire.

Authors:  H W Schroeder; J L Hillson; R M Perlmutter
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

6.  Human immunoglobulin VH and VK repertoire revealed by in situ hybridization.

Authors:  V Guigou; A M Cuisinier; C Tonnelle; D Moinier; M Fougereau; F Fumoux
Journal:  Mol Immunol       Date:  1990-09       Impact factor: 4.407

7.  Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.

Authors:  M Deane; J D Norton
Journal:  Eur J Immunol       Date:  1990-10       Impact factor: 5.532

8.  Conservation and divergence of immunoglobulin VH pseudogenes.

Authors:  J B Cohen; D Givol
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.

Authors:  E Roosnek; A Lanzavecchia
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin.

Authors:  S H Clarke; K Huppi; D Ruezinsky; L Staudt; W Gerhard; M Weigert
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  7 in total

1.  Sequence analyses of three immunoglobulin G anti-virus antibodies reveal their utilization of autoantibody-related immunoglobulin Vh genes, but not V lambda genes.

Authors:  D F Huang; T Olee; Y Masuho; Y Matsumoto; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Evidence that the V kappa III gene usage is nonstochastic in both adult and newborn peripheral B cells and that peripheral CD5+ adult B cells are oligoclonal.

Authors:  J C Weber; G Blaison; T Martin; A M Knapp; J L Pasquali
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

3.  Clonal analysis of a human antibody response. II. Sequences of the VH genes of human IgM, IgG, and IgA to rabies virus reveal preferential utilization of VHIII segments and somatic hypermutation.

Authors:  H Ikematsu; N Harindranath; Y Ueki; A L Notkins; P Casali
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

4.  VH and V kappa segment structure of anti-insulin IgG autoantibodies in patients with insulin-dependent diabetes mellitus. Evidence for somatic selection.

Authors:  H Ikematsu; Y Ichiyoshi; E W Schettino; M Nakamura; P Casali
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

5.  B cells from a distinct subset of patients with common variable immunodeficiency (CVID) have increased CD95 (Apo-1/fas), diminished CD38 expression, and undergo enhanced apoptosis.

Authors:  A Saxon; B Keld; D Diaz-Sanchez; B C Guo; N Sidell
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

6.  Variable region gene analysis of B cell subsets derived from a 4-year-old child: somatically mutated memory B cells accumulate in the peripheral blood already at young age.

Authors:  U Klein; R Küppers; K Rajewsky
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

7.  Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome.

Authors:  R N Haire; R D Buell; R T Litman; Y Ohta; S M Fu; T Honjo; F Matsuda; M de la Morena; J Carro; R A Good
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.